George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInvestment Co. Regulatory News (INV)

Share Price Information for Investment Co. (INV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 320.00
Bid: 312.00
Ask: 328.00
Change: 1.00 (0.31%)
Spread: 16.00 (5.128%)
Open: 319.00
High: 320.00
Low: 319.00
Prev. Close: 319.00
INV Live PriceLast checked at -
Investment Company is an Investment Trust

To provide shareholders with an attractive level of dividends coupled with capital growth over the long-term, through the investment in a portfolio of equities, preference shares, loan stocks, debentures and convertibles.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposals re Investment Manager & Shareholdings

30 Mar 2023 07:00

RNS Number : 6835U
Investment Company PLC
30 March 2023
 

The information contained within this announcement is considered by The Investment Company plc to constitute inside information pursuant to Article 7 of EU Regulation No. 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via a Regulatory Information Service, this inside information will be considered to be in the public domain.

 

The Investment Company plc

("The Investment Company" or the "Company")

Proposed appointment of Investment Manager, proposed board changes, proposed purchase by the Company of its own ordinary shares

and

Proposed issue of ordinary shares in the Company

 

Further to the Company's announcement on 20 February 2023, the board of The Investment Company is pleased to announce that, following a thorough review of available opportunities, the Company has entered into discussions to:

· appoint Chelverton Asset Management Limited ("Chelverton") to act as investment manager ("Investment Manager") to the Company with a new investment strategy of investing primarily in quoted equities of UK small and mid-cap quoted companies to achieve long-term capital growth;

· provide an opportunity for shareholders to either retain some or all of their shareholding in the Company with the proposed Investment Manager offering a new investment strategy or, alternatively, to realise their investment in cash (at the prevailing net asset value per ordinary share, adjusted for transaction costs); and

· undertake an issuance of ordinary shares to existing and new shareholders with the aim of increasing the size and liquidity of the Company,

(together the "Proposals").

Founded in 1998, Chelverton is an independent, employee-owned fund management firm with a strong focus on performance and investor outcomes. As at 28th February 2023 Chelverton managed c.£1.7bn across a number of mandates encompassing both open-ended and closed-ended UK and European focused-funds including the MI Chelverton UK Equity Growth Fund, managed by the UK Equity Growth Team. By focussing on long-term investor returns that can be generated by companies with rising cashflows, the team seeks to take advantage of the potential for superior long-term capital performance of certain UK small and mid-cap quoted companies.

Should the Proposals become effective, in order to generate long-term capital growth, the Company intends to pursue an investment strategy of investing in cash-generative UK small and mid-cap quoted companies that are expected to grow faster than the UK stock market as a whole over the long term and which can finance their own organic growth.

This strategy has been successfully deployed by the MI Chelverton UK Equity Growth Fund, which has returned 222.05% since launch in October 2014 (Source: Morningstar, NAV to NAV, B Shares Acc, Total Return to 28.02.2023).

It is intended that the Chelverton UK Equity Growth Team, comprising of James Baker, Ed Booth and Henry Botting would be responsible for the management of the Company's portfolio.

As part of the Proposals, certain employees of Chelverton intend to subscribe for ordinary shares in the Company.

It is also intended that David Horner (founder and Managing Director of Chelverton) will be appointed to the board of the Company (the "Board") as a non-executive director. David has indicated to the Board that he intends to waive his remuneration entitlement. Michael Weeks intends to step down from the Board on completion of the Proposals. The other directors of the Company are expected to remain as directors following completion of the Proposals.

The Board believes that the Proposals will provide shareholders with the opportunity to either remain in a vehicle managed by an award-winning asset manager with a strong track record of creating value for its investors, or to receive a full cash alternative for those shareholders who wish to realise their investment (through a process which is comparable in terms of cost, but more timely, than a liquidation of the Company).

Should the Proposals become effective, the continuing directors of the Company have expressed their intention to retain their full shareholdings in the Company.

The Proposals are conditional, inter alia, on shareholder approval and further announcements will be made as and when appropriate.

Ian Dighé, Chairman of The Investment Company, said:

"Having reviewed a number of potential opportunities and options available to the Company, we are pleased to be putting these proposals to shareholders. The directors believe that the proposals offer existing shareholders two appropriate alternatives: either to retain their shareholding in the Company whilst it pursues a growth mandate managed by a team with a proven track record, or to have their capital returned to them. The continuing directors look forward to retaining their shareholdings in the Company and working with the Chelverton team."

David Horner, Managing Director of Chelverton, said:

"We are investors with a long history of, and expertise in, investment in UK small- and mid-cap quoted companies who believe in the positive long-term compounding effect of rising corporate cashflows on shareholder returns. It feels to us that we are at a point in time where valuation levels in our investable universe are extremely attractive as we believe that interest rates are set to peak and economic growth is set to pick up."

Enquiries

The Investment Company plc Ian Dighé, Chairman

+44 (0) 20 3934 6630 info@theinvestmentcompanyplc.co.uk

 

Singer Capital Markets - Sponsor

+44 (0)20 7496 3000

James Moat / Alex Bond / Alex Emslie

 

Chelverton Asset Management Limited

David Horner/ Al Rae

+44 (0) 7222 8989

 

 

ISCA Administration Services Limited

Company Secretary

+44 (0) 1392 487056

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFIDVAIAFIV
Date   Source Headline
22nd Apr 20245:26 pmRNSNet Asset Value(s)
15th Apr 20244:57 pmRNSNet Asset Value(s)
9th Apr 20241:27 pmRNSNet Asset Value(s)
4th Apr 20241:29 pmRNSNet Asset Value(s)
25th Mar 20243:37 pmRNSNet Asset Value(s)
19th Mar 20243:33 pmRNSNet Asset Value(s)
12th Mar 20249:58 amRNSNet Asset Value(s)
5th Mar 20242:56 pmRNSNet Asset Value(s)
28th Feb 20247:00 amRNSHalf-year Report
27th Feb 202412:54 pmRNSNet Asset Value(s)
19th Feb 20244:00 pmRNSNet Asset Value(s)
15th Feb 20244:24 pmRNSDirector Declaration
6th Feb 20241:34 pmRNSNet Asset Value(s)
29th Jan 202410:24 amRNSNet Asset Value(s)
22nd Jan 20245:38 pmRNSNet Asset Value(s)
16th Jan 202410:39 amRNSNet Asset Value(s)
9th Jan 20241:55 pmRNSNet Asset Value(s)
4th Jan 202411:45 amRNSNet Asset Value(s)
27th Dec 20232:08 pmRNSNet Asset Value(s)
18th Dec 20232:11 pmRNSNet Asset Value(s)
12th Dec 20239:32 amRNSNet Asset Value(s)
4th Dec 20231:20 pmRNSNet Asset Value(s)
27th Nov 20233:48 pmRNSNet Asset Value(s)
20th Nov 20233:24 pmRNSNet Asset Value(s)
13th Nov 202310:07 amRNSNet Asset Value(s)
10th Nov 202311:04 amRNSDirector/PDMR Shareholding
9th Nov 202312:07 pmRNSDirector/PDMR Shareholding
7th Nov 202312:03 pmRNSResult of AGM
2nd Nov 20235:04 pmRNSNet Asset Value(s)
31st Oct 20235:06 pmRNSNet Asset Value(s)
23rd Oct 20233:29 pmRNSNet Asset Value(s)
16th Oct 20235:11 pmRNSNet Asset Value(s)
9th Oct 20233:34 pmRNSNet Asset Value(s) - Amendment
9th Oct 20233:19 pmRNSNet Asset Value(s)
6th Oct 202312:02 pmRNSNet Asset Value(s)
4th Oct 20233:22 pmRNSFinal Results
25th Sep 20234:52 pmRNSNet Asset Value(s)
20th Sep 202310:47 amRNSNet Asset Value(s)
11th Sep 20234:40 pmRNSNet Asset Value(s)
9th Aug 20232:04 pmRNSNet Asset Value(s)
9th Aug 202311:24 amRNSHolding(s) in Company
8th Aug 20234:13 pmRNSHolding(s) in Company
1st Aug 202311:09 amRNSTotal Voting Rights
27th Jul 20234:11 pmRNSHolding(s) in Company
27th Jul 20232:36 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSAdmission, Director Dealings & Total Voting Rights
19th Jul 20237:00 amRNSCalculation of the Tender Price and Issue Price
18th Jul 20237:00 amRNSResult of Tender Offer and Issue
26th Jun 20233:55 pmRNSResult of Meeting
22nd Jun 202311:01 amRNSProspectus Correction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.